CUBT

$0.00

(

+0.00%

)
Quote details

stock

Curative Biotechnology Inc

NYSE MKT | CUBT

0.00

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 18, 2025)

$6.80M

Market Cap

-

P/E Ratio

0

EPS

$0.02

52 Week High

$0.00

52 Week Low

HEALTHCARE

Sector

CUBT Chart

Recent Chart
Price Action

CUBT Technicals

Tags:

CUBT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$92K
Total Revenue -
Cost Of Revenue $92K
Costof Goods And Services Sold $92K
Operating Income -$2.4M
Selling General And Administrative $2.2M
Research And Development $14K
Operating Expenses $2.3M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $92K
Income Before Tax -$3.6M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$2.4M
Ebitda -$2.3M
Net Income -$3.6M

Revenue & Profitability

Earnings Performance

CUBT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (None)
Total Assets $2.2M
Total Current Assets $212K
Cash And Cash Equivalents At Carrying Value $20K
Cash And Short Term Investments $20K
Inventory -
Current Net Receivables -
Total Non Current Assets $2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.3M
Intangible Assets Excluding Goodwill $1.3M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $192K
Other Non Current Assets -
Total Liabilities $7.1M
Total Current Liabilities $7.1M
Current Accounts Payable $4.1M
Deferred Revenue -
Current Debt -
Short Term Debt $1.4M
Total Non Current Liabilities -
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $1.6M
Other Non Current Liabilities -
Total Shareholder Equity -$4.9M
Treasury Stock -
Retained Earnings -$42M
Common Stock $92K
Common Stock Shares Outstanding $908M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (None)
Operating Cashflow -$1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $92K
Capital Expenditures $1
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $986K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$3.6M

yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$92K
Total Revenue -
Cost Of Revenue $92K
Costof Goods And Services Sold $92K
Operating Income -$2.4M
Selling General And Administrative $2.2M
Research And Development $14K
Operating Expenses $2.3M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $92K
Income Before Tax -$3.6M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$2.4M
Ebitda -$2.3M
Net Income -$3.6M

CUBT Profile

Curative Biotechnology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Curative Biotechnology, Inc. (CUBT) is a forward-thinking biomedical firm headquartered in Boca Raton, Florida, dedicated to pioneering advanced therapeutic solutions for unmet medical needs. Currently in the development phase, the company is focused on the research and commercialization of innovative biopharmaceuticals, leveraging cutting-edge biotechnology to enhance patient outcomes. With a robust pipeline and a commitment to transforming healthcare, Curative Biotechnology is strategically positioned to become a key player in the biopharmaceutical industry.

LPTX
+368.57%
$2.05
CANF
+5.00%
$0.38
ASBP
+15.77%
$0.10
NVDA
-2.80%
$181.36
ONDS
+25.33%
$7.84
PLUG
+2.63%
$2.14
WTO
-8.00%
$0.02
LOBO
+27.77%
$0.50
CHR
+0.63%
$0.04
VHAI
-33.33%
$0.00
ASST
+7.69%
$1.12
CMND
-21.84%
$0.21
OLMA
+136.38%
$20.14
TSLA
-1.87%
$401.25
F
+1.08%
$13.02
AXDX
-61.36%
$0.03
PFE
+1.47%
$25.45
SOFI
-2.95%
$26.24
BITF
+2.99%
$2.75
QUBT
+7.30%
$12.34
INTC
-1.09%
$34.33
AMZN
-4.43%
$222.55
WBD
+4.17%
$23.69
NIO
-1.64%
$5.98
GRAB
-0.18%
$5.32
DNN
-0.41%
$2.38
ACHR
+2.56%
$7.61
ETHD
-8.08%
$5.23
SNAP
+0.85%
$8.25
PLTR
-2.28%
$167.33
WULF
+8.59%
$12.00
BMNR
+4.29%
$32.28
ADAP
-15.14%
$0.05
MARA
+3.21%
$11.88
GOOGL
-0.25%
$284.28
CAN
+20.75%
$1.03
NOK
-0.30%
$6.64
AAL
+0.16%
$12.36
AAPL
0.00%
$267.44
AMD
-4.25%
$230.29
CIFR
+1.60%
$14.58
KVUE
-0.06%
$16.23
RGTI
+4.13%
$25.71
NFLX
+3.44%
$114.09
HPE
-1.55%
$20.90
BYND
-3.84%
$1.01
ABEV
-0.39%
$2.53
T
+0.51%
$25.60
TLRY
0.00%
$1.03
RIVN
+0.80%
$14.99
RMBL
+60.50%
$3.21
RIG
+1.22%
$4.13
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IREN
+3.03%
$48.85
GPUS
+0.84%
$0.24
RR
+3.84%
$3.24
RUBI
-4.22%
$0.16
BURU
-5.42%
$0.20
BAC
+0.31%
$51.64
SRM
+53.27%
$10.30
KXIN
+2.14%
$0.29
CLF
+2.00%
$11.19
MSFT
-2.69%
$493.79
PLTD
+2.29%
$7.12
MU
-5.55%
$228.50
CRWV
-0.57%
$74.90
LFS
+68.39%
$6.50
SOUN
+0.87%
$11.53
TWOH
+12.00%
$0.00
APLT
+4.99%
$0.29
QS
+0.15%
$12.97
BTBT
+3.47%
$2.38
EPSM
+91.54%
$2.72
GOOG
-0.22%
$284.96
BBD
-0.55%
$3.60
PCG
-1.10%
$16.15
ONFO
+11.48%
$0.94
BTG
0.00%
$3.99
HOOD
-1.44%
$114.30
BTE
+3.97%
$3.14
WLGS
-5.57%
$0.04
MRK
+3.84%
$96.43
SMCI
+2.34%
$34.90
MTSR
-0.35%
$70.50
QBTS
+0.43%
$22.93
IONZ
-5.35%
$4.77
AMCR
+0.11%
$8.46
DVLT
-6.16%
$1.75
APLD
-0.41%
$22.84
EOSE
+3.69%
$13.48
HIMS
+1.91%
$36.26
HBAN
+0.32%
$15.35
VALE
0.00%
$12.17
CGTL
-11.32%
$0.71
NBIS
+5.30%
$90.54
CLSK
+1.88%
$10.81
PLTZ
+4.50%
$7.42
CSCO
-0.52%
$77.37
RXRX
+0.97%
$4.16
LPTX
+368.57%
$2.05
CANF
+5.00%
$0.38
ASBP
+15.77%
$0.10
NVDA
-2.80%
$181.36
ONDS
+25.33%
$7.84
PLUG
+2.63%
$2.14
WTO
-8.00%
$0.02
LOBO
+27.77%
$0.50
CHR
+0.63%
$0.04
VHAI
-33.33%
$0.00
ASST
+7.69%
$1.12
CMND
-21.84%
$0.21
OLMA
+136.38%
$20.14
TSLA
-1.87%
$401.25
F
+1.08%
$13.02
AXDX
-61.36%
$0.03
PFE
+1.47%
$25.45
SOFI
-2.95%
$26.24
BITF
+2.99%
$2.75
QUBT
+7.30%
$12.34
INTC
-1.09%
$34.33
AMZN
-4.43%
$222.55
WBD
+4.17%
$23.69
NIO
-1.64%
$5.98
GRAB
-0.18%
$5.32
DNN
-0.41%
$2.38
ACHR
+2.56%
$7.61
ETHD
-8.08%
$5.23
SNAP
+0.85%
$8.25
PLTR
-2.28%
$167.33
WULF
+8.59%
$12.00
BMNR
+4.29%
$32.28
ADAP
-15.14%
$0.05
MARA
+3.21%
$11.88
GOOGL
-0.25%
$284.28
CAN
+20.75%
$1.03
NOK
-0.30%
$6.64
AAL
+0.16%
$12.36
AAPL
0.00%
$267.44
AMD
-4.25%
$230.29
CIFR
+1.60%
$14.58
KVUE
-0.06%
$16.23
RGTI
+4.13%
$25.71
NFLX
+3.44%
$114.09
HPE
-1.55%
$20.90
BYND
-3.84%
$1.01
ABEV
-0.39%
$2.53
T
+0.51%
$25.60
TLRY
0.00%
$1.03
RIVN
+0.80%
$14.99
RMBL
+60.50%
$3.21
RIG
+1.22%
$4.13
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IREN
+3.03%
$48.85
GPUS
+0.84%
$0.24
RR
+3.84%
$3.24
RUBI
-4.22%
$0.16
BURU
-5.42%
$0.20
BAC
+0.31%
$51.64
SRM
+53.27%
$10.30
KXIN
+2.14%
$0.29
CLF
+2.00%
$11.19
MSFT
-2.69%
$493.79
PLTD
+2.29%
$7.12
MU
-5.55%
$228.50
CRWV
-0.57%
$74.90
LFS
+68.39%
$6.50
SOUN
+0.87%
$11.53
TWOH
+12.00%
$0.00
APLT
+4.99%
$0.29
QS
+0.15%
$12.97
BTBT
+3.47%
$2.38
EPSM
+91.54%
$2.72
GOOG
-0.22%
$284.96
BBD
-0.55%
$3.60
PCG
-1.10%
$16.15
ONFO
+11.48%
$0.94
BTG
0.00%
$3.99
HOOD
-1.44%
$114.30
BTE
+3.97%
$3.14
WLGS
-5.57%
$0.04
MRK
+3.84%
$96.43
SMCI
+2.34%
$34.90
MTSR
-0.35%
$70.50
QBTS
+0.43%
$22.93
IONZ
-5.35%
$4.77
AMCR
+0.11%
$8.46
DVLT
-6.16%
$1.75
APLD
-0.41%
$22.84
EOSE
+3.69%
$13.48
HIMS
+1.91%
$36.26
HBAN
+0.32%
$15.35
VALE
0.00%
$12.17
CGTL
-11.32%
$0.71
NBIS
+5.30%
$90.54
CLSK
+1.88%
$10.81
PLTZ
+4.50%
$7.42
CSCO
-0.52%
$77.37
RXRX
+0.97%
$4.16

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.